Skip Navigation

News & Resources


Subscribe to NHLBI Press Releases
October 24, 2016

Toward Precision Medicine: First Whole Genomes from TOPMed Now Available for Study

In a bold step for precision medicine, researchers at the National, Heart, Lung, and Blood Institute (NHLBI) today announced they are releasing for study nearly 9,000 whole genomes, courtesy of participants in the Institute’s Trans-Omics for Precision Medicine Program (TOPMed). The genomes—an organism’s complete set of DNA—are the first ever to be made available by the program, and researchers hope they one day will lead to treatments tailor-made to the individual, as well as shed light on racial and ethnic health disparities.

September 30, 2016

NHLBI Awards Grants to Help Improve Health Outcomes for Teens, Adults with Sickle Cell Disease

WHAT: The National Heart, Lung, and Blood Institute (NHLBI) recently awarded nearly $36 million in grants to help improve the quality of health care for U.S. teens and adults with sickle cell disease. The grants are the first of their kind dedicated to testing strategies that could boost health outcomes for this group of young adults. The grants were awarded to eight clinical sites across the country as part of the Sickle Cell Disease Implementation Consortium (SCDIC) project.

Subscribe to NHLBI In The News
October 25, 2016 :

Researchers are reporting that they have developed compounds that have the potential to be developed into new drugs for treating certain diseases involving mitochondria, known as the cell’s powerhouse.  Those diseases include Charcot-Marie-Tooth disease, an inherited disorder that leads to loss of motor neurons and eventually paralysis.  In lab studies using mouse cells, the researchers demonstrated that they could use the compounds to control the activity of a key protein, called mitofusin 2, that is disabled in the mitochondria of patients with this disease.  Scientists believe that the finding may eventually have applications in treating other diseases, including heart disease and diabetes, which aren’t generally thought to be diseases of the mitochondria.  The study, partly funded by NHLBI, appeared in Nature.

October 20, 2016 : Science Daily

An NHLBI funded study finds that calorie labels in fast-food restaurants have little impact on consumers’ food choices. The research, published in the Journal of Public Policy & Marketing, makes recommendations to improve the calorie labeling policy to encourage changes in eating behavior.

October 24, 2016 to October 25, 2016
Natcher Conference Center(Building 45) Bethesda, Maryland
The conference Unraveling Vascular Inflammation: From Immunology to Imaging 2016, sponsored by the National Heart, Lung and Blood Institutes (NHLBI) of the National Institutes of Health (NIH), seeks to convene scientists, researchers and physicians from around the world with an interest in immunology, human translational studies involving cardiovascular imaging and quantification. Hosted at the NIH campus, in Bethesda, MD, October 24 and 25, the day and a half conference will feature three keynote speakers (immunology, human inflammation and imaging), poster session and competition (including cash poster award and A High-Yield Series of Imaging Talks, a rapid fire series of 10 minutes talks by leading imaging scientists in the field.
November 1, 2016 to November 3, 2016
NHLBI Innovation Conference NHLBI’s Office of Translational Alliances and Coordination (OTAC) hosts the NHLBI Innovation Conference to connect NHLBI-funded companies with investors, strategic partners, and business leaders from the biotech, medical device, and pharmaceutical industries.